Aaplans Pharma Private Limited
About Aaplans Pharma Private Limited
Data last updated:
Aaplans Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 03 July 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC174530.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Sudheera Guduru and Raja Gopal Reddy Guduru.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.04 Cr. For the same year it recorded a net profit of ₹75.24 Lakh (net margin 3.8%) and EBITDA of ₹1.03 Cr (EBITDA margin 5.2%).
Company details
Contact details
Aaplans Pharma Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressFlat No .402, Janasai Residency, Hyderabad, Telangana, India – 500032
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aaplans Pharma Private Limited
FY 2025 filings availableAaplans Pharma Private Limited reported revenue of ₹20.04 Cr for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.03 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹75.24 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.2% | |
| Net Profit Margin | 3.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Aaplans Pharma Private Limited, buy the company report.
Board of directors of Aaplans Pharma Private Limited
Aaplans Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siva Pratheek Guduru Also directs: Polycarp Chemicals LLP | Additional Director | 17 Nov 2023 | 2 Years 11 Months | Current |
| Sudheera Guduru | Director | 03 Jul 2023 | 3 Years 4 Months | Current |
| Raja Gopal Reddy Guduru | Director | 03 Jul 2023 | 3 Years 4 Months | Current |
Peer comparison
Aaplans Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tesla Chemicals Private Limited | ₹20.24 Cr (FY 2025) | -18.0% | Panoli, Gujarat, India | |||
| Pharchem Private Limited | ₹20.2 Cr (FY 2024) | 0.0% | Boisar, Maharashtra, India | |||
| Suyog Life Sciences Private Limited | ₹20.09 Cr (FY 2025) | -1.0% | Ankleshwar, Gujarat, India | |||
| Frinze Laboratories Private Limited | ₹20.07 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Auro Laboratories Limited | ₹20.05 Cr (FY 2025) | -64.0% | Thane, Maharashtra, India | |||
| Aaplans Pharma Private Limitedthis company | ₹20.04 Cr (FY 2025) | ₹75.24 Lakh | 3.8% | Hyderabad, Telangana, India | ||
| Asai Vishwa Speciality Chemicals Private Limited | ₹19.73 Cr (FY 2024) | -13.0% | Navi Mumbai, Maharashtra, India | |||
| Equatorial Private Limited | ₹19.61 Cr (FY 2018) | 22832.0% | Ahmedabad, Gujarat, India | |||
| Taaj Health Care Chemicals Private Limited | ₹19.54 Cr (FY 2024) | 233.0% | Thane, Maharashtra, India | |||
| Vilarsh Healthcare Private Limited | ₹19.52 Cr (FY 2025) | 188.0% | Delhi, India | |||
| Vihita Bio-Chem Private Limited | ₹19.24 Cr (FY 2025) | 30.0% | Bharuch, Gujarat, India |
To see the full peer comparison of Aaplans Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aaplans Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aaplans Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aaplans Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aaplans Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Siva Pratheek Guduru was appointed as Additional Director on 17 Nov 2023.
Frequently asked questions
Aaplans Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 03 July 2023 (3+ years old) and is registered under CIN U21001TS2023PTC174530.
Aaplans Pharma has 3 current directors:
- Siva Pratheek Guduru - Additional Director
- Sudheera Guduru - Director
- Raja Gopal Reddy Guduru - Director
The latest financial statements of Aaplans Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Aaplans Pharma is U21001TS2023PTC174530. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aaplans Pharma was incorporated on 03 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aaplans Pharma by revenue are Tesla Chemicals Private Limited, Pharchem Private Limited, Suyog Life Sciences Private Limited, Frinze Laboratories Private Limited, Auro Laboratories Limited and 5 more, all in the Pharma industry (API Manufacturers).
Siva Pratheek Guduru was appointed as Additional Director on 17 Nov 2023. Raja Gopal Reddy Guduru was appointed as Director on 03 Jul 2023. Sudheera Guduru was appointed as Director on 03 Jul 2023.
The registered office of Aaplans Pharma is at Flat No .402, Janasai Residency, Hyderabad, Telangana, India – 500032.
Aaplans Pharma operates in the paper industry, in the paper and paper products segment.
Aaplans Pharma can be reached at its registered office: Flat No .402, Janasai Residency, Hyderabad, Telangana, India – 500032.
Aaplans Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
